Awardee OrganizationUNIVERSITY OF CALIFORNIA, SAN DIEGO
Description
Abstract Text
OVERALL - PROJECT SUMMARY
The mission of the National Resource for Network Biology (NRNB) is to advance the science of biological
networks by creating leading-edge bioinformatic methods, software tools and infrastructure, and by engaging
the scientific community in a portfolio of collaboration and training opportunities. Much of biomedical research
is dependent on knowledge of biological networks of multiple types and scales, including molecular interactions
among genes, proteins, metabolites and drugs; cell communication systems; relationships among genotypes
and biological and clinical phenotypes; and patient and social networks. NRNB-supported platforms like
Cytoscape are among the most widely used software tools in biology, with tens of thousands of active users,
enabling researchers to apply network concepts and data to understand biological systems and how they are
reprogrammed in disease.
NRNB’s three Technology Research and Development projects introduce innovative concepts with the
potential to transform network biology, transitioning it from a static to a dynamic science (TR&D 1); from flat
network diagrams to multi-scale hierarchies of biological structure and function (TR&D 2); and from descriptive
interaction maps to predictive and interpretable machine learning models (TR&D 3). In previous funding
periods our technology projects have produced novel and highly cited approaches, including network-based
biomarkers for stratification of disease, data-driven gene ontologies assembled completely from network data,
and deep learning models of cell structure and function built using biological networks as a scaffold.
During the next period of support, we introduce dynamic regulatory networks formulated from single-cell
transcriptomics and advanced proteomics data (TR&D 1); substantially improved methodology for the study of
hierarchical structure and pleiotropy in biological networks (TR&D 2); and procedures for using networks to
seed machine learning models of drug response that are both mechanistically interpretable and transferable
across biomedical contexts (TR&D 3). These efforts are developed and applied in close collaboration with
outside investigators from 19 Driving Biomedical Projects who specialize in experimental generation of network
data, disease biology (cancer, neuropsychiatric disorders, diabetes), single-cell developmental biology, and
clinical trials. TR&Ds are also bolstered by 7 Technology Partnerships in which NRNB scientists coordinate
technology development with leading resource-development groups in gene function prediction, mathematics
and algorithm development, and biomedical databases. Beyond these driving collaborations, we continually
support a broader portfolio of transient (non-driving) research collaborations; organize and lead international
meetings including the popular Network Biology track of the Intelligent Systems for Molecular Biology
conference; and deliver a rich set of training opportunities and network analysis protocols.
Public Health Relevance Statement
OVERALL - PROJECT NARRATIVE
We are all familiar with some of the components of biological systems – DNA, proteins, cells, organs,
individuals – but understanding biological systems involves more than just cataloging its component parts. It is
critical to understand the many interactions of these parts within systems, and how these systems give rise to
biological functions and responses and determine states of health and disease. The National Resource for
Network Biology provides the scientific community with a broad platform of computational tools for the study of
biological networks and for incorporating network knowledge in biomedical research.
No Sub Projects information available for 5P41GM103504-12
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P41GM103504-12
Patents
No Patents information available for 5P41GM103504-12
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P41GM103504-12
Clinical Studies
No Clinical Studies information available for 5P41GM103504-12
News and More
Related News Releases
No news release information available for 5P41GM103504-12
History
No Historical information available for 5P41GM103504-12
Similar Projects
No Similar Projects information available for 5P41GM103504-12